Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2005; 11(22): 3339-3345
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3339
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3339
Figure 6 Immunohistochemistry results of the tumor specimen before and after CIK treatment, demonstrated that a large amount of lymphocytes with CD3, CD45, CD45RO, CD68 markers infiltrated in tumor after treatment.
A: Immunohistochemistry with anti-CD3 to the specimen before treatment; B: with anti-CD3 to the specimen after treatment; C: immunohistochemistry with anti-CD45 to the specimen before treatment; D: with anti-CD45 to the specimen after treatment; E: immunohistochemistry with anti-CD45RO to the specimen before treatment; F: with anti-CD45RO to the specimen after treatment; G: immunohistochemistry with anti-CD68 to the specimen before treatment; H: with anti-CD68 to the specimen after treatment.
- Citation: Zhang YS, Yuan FJ, Jia GF, Zhang JF, Hu LY, Huang L, Wang J, Dai ZQ. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R. World J Gastroenterol 2005; 11(22): 3339-3345
- URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3339.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3339